Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
HKEX:2607
Holding HK:2607?
Track your performance easily
See the Price Targets and Ratings of:
2607 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2607 Stock 12 Month Forecast
There Are No Analyst Ratings for HK:2607 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
2607 Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
HK$17→HK$17.5
Buy
36.29%
Upside
Reiterated
06/06/24
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Raised to HK$17.50 at Morgan StanleyMorgan Stanley analyst Laurence Tam raised the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$17.50 (from HK$17.00) while maintaining a Overweight rating.
Goldman Sachs
HK$13.98→HK$13.44
Sell
4.67%
Upside
Reiterated
04/03/24
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$13.44 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$13.44 (from HK$13.98) while maintaining a Sell rating.
Unknown Analyst
Not Ranked
CLSA
HK$15.5→HK$13.54
Buy
5.45%
Upside
Reiterated
03/31/24
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$13.54 at CLSACLSA analyst John Yung lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$13.54 (from HK$15.50) while maintaining a Buy (1) rating.
Best Analysts Covering Shanghai Pharmaceuticals Holding Co
Which Analyst Should I Follow If I Want to Buy HK:2607 and Sell After:
1 Month
xxx
Success Rate
2/2 ratings generated profit
Average Return
+5.15%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +5.15% per trade.
3 Months
xxx
Success Rate
1/2 ratings generated profit
Average Return
-0.55%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.55% per trade.
1 Year
Success Rate
2/2 ratings generated profit
Average Return
+29.00%
reiterated a buy rating 6 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +29.00% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
Average Return
+29.00%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +29.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2607 Analyst Recommendation Trends
Rating
Oct 23
Nov 23
Dec 23
Apr 24
Jun 24
Strong Buy
0
1
2
2
2
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
2
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
2607 Stock Forecast FAQ
What is HK:2607’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2607’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2607, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Shanghai Pharmaceuticals Holding Co Ltd Class H a Buy, Sell or Hold?
Currently, no data Available
What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s share price target?
Currently, no data Available
What do analysts say about Shanghai Pharmaceuticals Holding Co Ltd Class H?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Shanghai Pharmaceuticals Holding Co Ltd Class H?
To buy shares of HK:2607, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.